These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34605776)

  • 1. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
    Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
    Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
    Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
    Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
    Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
    Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled Analysis.
    Knaak C; Schuster FS; Nyvlt P; Spies C; Feinkohl I; Beutel G; Schenk T; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care Med; 2020 Nov; 48(11):e1137-e1146. PubMed ID: 32947471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.
    Griffin G; Shenoi S; Hughes GC
    Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101515. PubMed ID: 32387063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge].
    Ruffer N; Kosch R; Weisel K; Kötter I; Krusche M
    Z Rheumatol; 2024 Jun; 83(5):376-386. PubMed ID: 38267764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
    Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
    Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
    Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.
    Valade S; Mariotte E; Azoulay E
    Crit Care Clin; 2020 Apr; 36(2):415-426. PubMed ID: 32172822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
    Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
    La Rosée P; Horne A; Hines M; von Bahr Greenwood T; Machowicz R; Berliner N; Birndt S; Gil-Herrera J; Girschikofsky M; Jordan MB; Kumar A; van Laar JAM; Lachmann G; Nichols KE; Ramanan AV; Wang Y; Wang Z; Janka G; Henter JI
    Blood; 2019 Jun; 133(23):2465-2477. PubMed ID: 30992265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Activation Syndrome in Children: Diagnosis and Management.
    Bagri NK; Gupta L; Sen ES; Ramanan AV
    Indian Pediatr; 2021 Dec; 58(12):1155-1161. PubMed ID: 33772536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
    Henderson LA; Cron RQ
    Paediatr Drugs; 2020 Feb; 22(1):29-44. PubMed ID: 31732958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
    Summerlin J; Wells DA; Anderson MK; Halford Z
    Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.
    Ehl S; Astigarraga I; von Bahr Greenwood T; Hines M; Horne A; Ishii E; Janka G; Jordan MB; La Rosée P; Lehmberg K; Machowicz R; Nichols KE; Sieni E; Wang Z; Henter JI
    J Allergy Clin Immunol Pract; 2018; 6(5):1508-1517. PubMed ID: 30201097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
    Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
    Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.